price
RG
NASDAQ · RGC
Regencell Bioscience Holdings Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$5.60
Up+$0.08 (+1.43%)
Updated Sep 16, 2026, 9:48 PM
SID Score
3.8/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 8.33B
- P/E ratio
- -2,324.68
- Dividend yield
- 0.00%
- 52-week range
- $4.51 – $69.00
- Volume
- 71.95K
- Avg. volume
- 194.68K
Price performance
RGC price history
1M range · 20 trading sessions · Daily adjusted prices
RGC closed at $5.60 after 20 trading sessions, up 2.56% for the selected period.
- Last close
- $5.60
- Period change
- +2.56%
- Period low
- $5.29
- Period high
- $6.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $5.77 | $5.77 | $5.49 | $5.60 | 71.95K |
| Sep 14, 2026 | $5.63 | $5.84 | $5.63 | $5.74 | 73.03K |
| Sep 11, 2026 | $5.84 | $5.84 | $5.55 | $5.64 | 102.33K |
| Sep 10, 2026 | $5.95 | $6.20 | $5.5617 | $5.635 | 203.56K |
| Sep 9, 2026 | $6.72 | $6.7425 | $5.72 | $5.85 | 292.58K |
| Sep 8, 2026 | $6.91 | $7.1371 | $6.42 | $6.82 | 316.68K |
| Sep 4, 2026 | $6.43 | $7.65 | $6.35 | $6.89 | 659.35K |
| Sep 3, 2026 | $6.32 | $6.90 | $5.93 | $6.48 | 416.49K |
| Sep 2, 2026 | $5.44 | $6.60 | $5.44 | $6.31 | 373.69K |
| Sep 1, 2026 | $5.38 | $5.51 | $5.18 | $5.50 | 102.53K |
| Aug 31, 2026 | $5.50 | $5.54 | $5.43 | $5.51 | 40.32K |
| Aug 28, 2026 | $5.50 | $5.70 | $5.44 | $5.50 | 73.41K |
| Aug 27, 2026 | $5.52 | $5.63 | $5.4255 | $5.52 | 73.86K |
| Aug 26, 2026 | $5.53 | $5.58 | $5.40 | $5.50 | 61.58K |
| Aug 25, 2026 | $5.39 | $5.55 | $5.17 | $5.54 | 79.38K |
| Aug 24, 2026 | $5.30 | $5.35 | $5.16 | $5.29 | 150.45K |
| Aug 21, 2026 | $5.44 | $5.50 | $5.22 | $5.30 | 153.53K |
| Aug 20, 2026 | $5.76 | $6.055 | $5.37 | $5.44 | 140.99K |
| Aug 19, 2026 | $5.42 | $6.135 | $5.42 | $5.81 | 256.92K |
| Aug 18, 2026 | $5.32 | $5.54 | $5.2194 | $5.46 | 88.75K |
Latest RGC news
The latest Smart Investors Daily articles mentioning RGC.
Stock researchResearch & News · SEC Filings
Loading stock research…